$2.25bn worth medical devices industry M&A deals announced globally in Q2 2020

Comparing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $1.85bn. At the country level, the US topped the list in terms of deal value at $1.78bn.

In terms of volumes, North America emerged as the top region for medical devices industry M&A deals globally, followed by Europe and then Asia-Pacific.

The top country in terms of M&A deals activity in Q2 2020 was the US with 48 deals, followed by Canada with seven and Germany with seven.

In 2020, as of the end of Q2 2020, medical devices M&A deals worth $16.31bn were announced globally, marking a decrease of 29.3% year on year.

Medical devices industry M&A deals in Q2 2020: Top deals

The top five medical devices industry M&A deals accounted for 84.8% of the overall value during Q2 2020.

The combined value of the top five medical devices M&A deals stood at $1.9bn, against the overall value of $2.25bn recorded for the month.

The top five medical devices industry deals of Q2 2020 tracked by GlobalData were:

• InVitae’s $1.4bn acquisition of ArcherDx
• The $200m asset transaction with CareZone by Walmart
• Funai Electric’s $167.7m acquisition of Plexion
• The $90m acquisition of Artegraft by LeMaitre Vascular
• Richards Packaging Income Fund’s acquisition of Clarion Medical Technologies for $46.74m.